Tegoprazan-containing Sequential for H. Pylori
ConditionHelicobacter Pylori Infection
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSeoul National University Bundang Hospital
About this trial
As H. pylori eradication, the investigators prepared a randomized controlled clinical trial whether tegoprazan-containing 10-day sequential treatment was effective compared to conventional PPI-containing 10-day sequential eradication therapy
Eligibility criteria
Qualifiers
None
Disqualifiers
congestive heart failure, NYHA III or IV
end-stage renal disease
alcoholics
drug abusers
Trial design
Treatments tested in this trial
- Tegoprazan-containing sequential H. pylori eradication therapy
- Esomeprazole-containing sequential H. pylori eradication therapy
Treatment groups
400 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov